Cargando…

Increased PAI-1 plasma levels and risk of death from dengue: no association with the 4G/5G promoter polymorphism

BACKGROUND: Dengue virus infected patients have high plasminogen activator inhibitor type I (PAI-1) plasma concentrations. Whether the insertion/deletion (4G/5G) polymorphism in the promotor region of the PAI-1 gene is associated with increased PAI-1 plasma concentrations and with death from dengue...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mairuhu, ATA, Setiati, TE, Koraka, P, Hack, CE, Leyte, A, Faradz, SMH, ten Cate, H, Brandjes, DPM, Osterhaus, ADME, Reitsma, PH, van Gorp, ECM
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Original Clinical Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1308869/ https://www.ncbi.nlm.nih.gov/pubmed/16274483 http://dx.doi.org/10.1186/1477-9560-3-17

Ejemplares similares

Differential Gene Expression Changes in Children with Severe Dengue Virus Infections
por: de Kruif, Martijn D., et al.
Publicado: (2008)

Dengue disease severity in Indonesian children: an evaluation of the World Health Organization classification system
por: Setiati, Tatty E, et al.
Publicado: (2007)

Plasma Levels of Inter-α Inhibitor Proteins in Children with Acute Dengue Virus Infection
por: Koraka, Penelope, et al.
Publicado: (2010)

The 4G/4G Genotype of PAI-1 Polymorphism Is Associated with Higher Plasma PAI-1 Concentrations and Mortality in Patients with Severe Sepsis
por: Lorente, Leonardo, et al.
Publicado: (2015)

Pauli Manuscript Collection: A. Pais and G. E. Uhlenbeck
por: Pauli, Wolfgang
Publicado: (2002)

Role of 4G/5G plasminogen activator inhibitor-1 (PAI-1) gene polymorphism and the PAI-1 plasma levels in the outcome of patients with severe sepsis
por: Lorente, L, et al.
Publicado: (2009)

The Role of TPA I/D and PAI-1 4G/5G Polymorphisms in Multiple Sclerosis
por: Živković, Maja, et al.
Publicado: (2014)

Relationship between post-SARS osteonecrosis and PAI-1 4G/5G gene polymorphisms
por: Sun, Wei, et al.
Publicado: (2013)

Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism
por: Wang, Ziran, et al.
Publicado: (2022)

In Black South Africans from Rural and Urban Communities, the 4G/5G PAI-1 Polymorphism Influences PAI-1 Activity, but Not Plasma Clot Lysis Time
por: de Lange, Zelda, et al.
Publicado: (2013)

Emerging viruses
por: Lipkin, W Ian, et al.
Publicado: (2013)

PAI-1 4G/5G Polymorphism Contributes to Cancer Susceptibility: Evidence from Meta-Analysis
por: Wang, Shangqian, et al.
Publicado: (2013)

The Effect of PAI-1 4G/5G Polymorphism and Clinical Factors on Coronary Artery Occlusion in Myocardial Infarction
por: Parpugga, Tajinder Kumar, et al.
Publicado: (2015)

PAI‐1 5G/5G genotype is an independent risk of intracranial hemorrhage in post‐lysis stroke patients
por: Szegedi, István, et al.
Publicado: (2019)

Association of G894T eNOS, 4G/5G PAI and T1131C APOA5 polymorphisms with susceptibility to myocardial infarction in Morocco
por: Hassani Idrissi, Hind, et al.
Publicado: (2016)

Association between the -844 G>A, HindIII C>G, and 4G/5G PAI-1 Polymorphisms and Susceptibility to Multiple Sclerosis in Western Mexican Population
por: Valdés-Alvarado, Emmanuel, et al.
Publicado: (2019)

Proceedings Fifth ESWI Influenza Conference
por: Osterhaus, A.D.M.E., et al.
Publicado: (2015)

PAI-1 promoter 4G/5G polymorphism (rs1799768) contributes to tumor susceptibility: Evidence from meta-analysis
por: XU, XIN, et al.
Publicado: (2012)

PAI-1 -675 4G/5G Polymorphism in Association with Diabetes and Diabetic Complications Susceptibility: a Meta-Analysis Study
por: Xu, Kuanfeng, et al.
Publicado: (2013)

Association Between - 675 ID, 4G/5G PAI-1 Gene Polymorphism and Pregnancy Loss: A Systematic Review
por: Adler, Grazyna, et al.
Publicado: (2018)

The Role of Pai-1 Gene 4g/5g Polymorphism and Diagnostic Value of Biomarkers in Allergic and Non-Allergic Asthma Phenotype
por: Lampalo, Marina, et al.
Publicado: (2018)

Correlation Between PAI-1 Gene 4G/5G Polymorphism and the Risk of Thrombosis in Ph Chromosome-Negative Myeloproliferative Neoplasms
por: Zhang, Xueya, et al.
Publicado: (2020)

The -844 G>A PAI-1 Polymorphism Is Associated with Acute Coronary Syndrome in Mexican Population
por: García-González, Ilian Janet, et al.
Publicado: (2015)

Genotype Variations and Association between PAI-1 Promoter Region (4G/5G and -844G/A) and Susceptibility to Acute Myocardial Infarction and Chronic Stable Angina
por: Kumar, Sunil, et al.
Publicado: (2021)

Relationship of metabolic syndrome and its components with -844 G/A and HindIII C/G PAI-1 gene polymorphisms in Mexican children
por: De la Cruz-Mosso, Ulises, et al.
Publicado: (2012)

Circulating Levels of PAI-1 and SERPINE1 4G/4G Polymorphism Are Predictive of Poor Prognosis in HCC Patients Undergoing TACE()
por: Divella, Rosa, et al.
Publicado: (2015)

Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy
por: Jevrić, Marko, et al.
Publicado: (2019)

Polymorphism of the PAI-1gene (4G/5G) may be linked with Polycystic Ovary Syndrome and associated pregnancy disorders in South Indian Women
por: Mary, Maniraja Jesintha, et al.
Publicado: (2017)

Combined Effect of MTHFR C677T and PAI-1 4G/5G Polymorphisms on the Risk of Venous Thromboembolism in Chinese Lung Cancer Patients
por: Wang, Baoyan, et al.
Publicado: (2021)

Association of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene -675 4G/5G and -844 A/G Promoter Polymorphism with Risk of Keloid in a Chinese Han Population
por: Wang, Yongjie, et al.
Publicado: (2014)

Association of -675 4G/5G PAI-1 and -2518A/G MCP-1 genetic polymorphisms with polycystic ovary syndrome in Kashmiri women: A case control study
por: Yousuf, Syed Douhath, et al.
Publicado: (2022)

Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study
por: Yousef, Aly A, et al.
Publicado: (2020)

Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study [Corrigendum]
Publicado: (2021)

A meta-analysis of the association of the ACE I/D and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Iranian women: Are the investigations adequate?
por: Dastgheib, Seyed Alireza, et al.
Publicado: (2021)

Conditioned media from (pre)adipocytes stimulate fibrinogen and PAI-1 production by HepG2 hepatoma cells
por: Faber, D R, et al.
Publicado: (2012)

El País.
Publicado: (1983)

País portátil
por: González León, Adriano
Publicado: (1969)

4G/5G polymorphism of PAI-1 gene is associated with multiple organ dysfunction and septic shock in pneumonia induced severe sepsis: prospective, observational, genetic study
por: Madách, Krisztina, et al.
Publicado: (2010)

País : antología 1955-1970 /
por: Otero, Blas de
Publicado: (1974)

Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and risk of Alzheimer's disease, metabolic syndrome, and female infertility: A meta-analysis
por: Zhang, Xin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cs7097v70aevsjfirglfmdjbg3